Schroders plans to launch a new high conviction global equity fund, Schroder Global Alpha Plus, in May.
Subject to FSA approval, the Schroder Global Alpha Plus fund will typically invest in 30 stocks and will be run by experienced institutional managers Virginie Maisonneuve and Jonathan Armitage.
Maisonneuve is the group's head of global equities and Armitage is head of US equities. The managers have a combined 39 years experience managing money.
The group already runs four high conviction Alpha Plus equity portfolios - Richard Buxton's UK Alpha Plus, Leon Howard-Spink's European Alpha Plus, Nathan Gibbs' Japan Alpha Plus and Matthew Dobbs' Asian Alpha Plus.
Schroder Global Alpha Plus aims to provide long-term outperformance of the MSCI World Total Return index from a benchmark unconstrained portfolio of the managers' best ideas.
Maisonneuve says the fund will provide investors managed exposure to best stock ideas independent of base currency and regional origin.
"We take a fundamentally-driven, bottom-up approach to identifying attractively-valued, quality growth stocks with strong sustainable competitive advantage," she says.
"This approach is supplemented by a thematic assessment, which focuses on climate change, demographics and the growing significance of emerging market countries in the world economy.
"We believe this assessment highlights long-term structural growth trends that are often underestimated from a purely bottom-up perspective."
Schroders managing director of UK intermediary Robin Stoakley adds: "As with our other Alpha funds, we are giving two of Schroders' best managers the freedom to make money for investors.
"They will do that through a concentrated, best ideas approach combining the best of Schroders' fundamental stock analysis and thematic research."
The fund's initial charge is 5.25% and AMC is 1.5%. Minimum investment is £1,000 or regular payments of £50 per month.
Suspension remains 'in best interests of all investors'
Our weekly heads-up for advisers
'UK investment case remains strong'
'No viable alternative'